Testing a questionnaire about steroid treatment effects on quality of life
Official title: Cross-condition Validation of the Patient Reported Outcome Measure for Patients Receiving Glucocorticoids (the Steroid PRO)
Run by University of the West of England · NCT06314451 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a new questionnaire to see how steroid treatment affects the quality of life for adults with inflammatory and autoimmune conditions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of the West of England Academic / other |
| Locations | 1 site (Bristol) |
| Trial ID | NCT06314451 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and over diagnosed with autoimmune or inflammatory conditions who have been treated with glucocorticoids within the past year.
✕Probably not a fit
Patients under 18 or those not diagnosed with relevant autoimmune or inflammatory conditions will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to validate a questionnaire designed to assess the impact of glucocorticoid treatment on the quality of life of patients with various inflammatory and autoimmune conditions. Participants aged 18 and over, who are currently taking steroids for conditions affecting the skin, lungs, or gastrointestinal tract, will be interviewed to provide feedback on the questionnaire's relevance and clarity. The study involves a single interview conducted online or by telephone, where participants will discuss their experiences and the questionnaire's content. The research is funded by Sanofi and conducted by independent researchers at the University of the West of England.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of how steroid treatments affect patients' daily lives, leading to improved patient care and management.
How similar studies have gone: Previous studies have successfully utilized patient-reported outcomes to assess treatment impacts, suggesting this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged ≥ 18 years old * Diagnosed with an autoimmune or inflammatory respiratory, gastroenterology or dermatology condition * Treatment with glucocorticoids with intravenous or oral glucocorticoids for an autoimmune or inflammatory condition within the previous year (or longer duration). * Ability to give consent. Exclusion Criteria: * Aged \<18 years old * No autoimmune or inflammatory respiratory, gastroenterology or dermatology diagnosis * Not treated with glucocorticoids with intravenous or oral glucocorticoids for an autoimmune or inflammatory condition within the previous year (or longer duration) * Unable to give consent
Where it's running
-
University of the West of England
Bristol, United Kingdom Recruiting
Study contacts
- Principal investigator: Joanna C Robson, FRCP PhD — University of the West of England
- Study coordinator: Joanna C Robson, FRCP PhD
- Email: jo.robson@uwe.ac.uk
- Phone: 0117 3427418
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multimodal Eye Data Bank to Explore Inflammation-Related Eye Diseases
This observational effort collects rich eye-imaging data from people with inflammatory and retinal conditions to see how the front and back of the eye relate and to build a standardized database that could support future AI tools.
-
Camoteskimab in adults with moderate-to-severe atopic dermatitis
This trial tests different doses of camoteskimab versus placebo to see if it helps adults with moderate-to-severe atopic dermatitis who have not fully responded to standard treatments.
-
Multicenter chest X-ray screening for thoracic diseases
This project will test whether routine chest X-rays can detect thoracic problems in adults who come for routine health examinations.
-
Microbiome in esophageal and stomach leaks
This project will test whether microbes in leaked fluid and nearby tissue from adults with esophageal or stomach leaks differ in ways that affect healing and complications.
-
Signia circular stapler for left-sided colon, sigmoid, and rectal resections
This study will try the Signia circular stapler with Tri-Staple technology to see if it safely creates bowel reconnections in adults having left-sided colon, sigmoid, or rectal surgery.
-
PF-08634404 plus chemotherapy for adults with metastatic colorectal cancer
This trial will test whether adding a new drug called PF-08634404 to standard chemotherapy helps adults whose colorectal cancer has spread.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.